References:
  1. Burns, J. C., Kushner, H. I., Bastian, J. F., Shike, H., Shimizu, C., Matsubara, T., & Turner, C. L. (2000). Kawasaki disease: a brief history. Pediatrics106 (2), e27-e27.
  2. Friedman, K. G., Gauvreau, K., Hamaoka‐Okamoto, A., Tang, A., Berry, E., Tremoulet, A. H., … & Newburger, J. W. (2016). Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. Journal of the American Heart Association5 (9), e003289.
  3. Rozo JC, Jefferies JL, Eidem BW, Cook PJ. Kawasaki disease in the adult: a case report and review of the literature. Tex Heart Inst J 2004;31(2):160-164.
  4. Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., … & Taubert, K. A. (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation110 (17), 2747-2771.
  5. Díaz-Zamudio M, Bacilio-Pérez U, Herrera-Zarza MC, Meave-González A, Alexanderson-Rosas E, Zambrana-Balta GF, Kimura-Hayama ET. Coronary artery aneurysms and ectasia: role of coronary CT angiography.Radiographics 2009;29(7):1939-54.
  6. Pham, V., de Hemptinne, Q., Grinda, J. M., Duboc, D., Varenne, O., & Picard, F. (2020). Giant coronary aneurysms, from diagnosis to treatment: a literature review. Archives of cardiovascular diseases113 (1), 59-69.
  7. Syed, M., & Lesch, M. (1997). Coronary artery aneurysm: a review. Progress in cardiovascular diseases40 (1), 77-84.
  8. Pfister, R., Sadeghi, Y., Orrit, J., & Prêtre, R. (2019). Giant coronary aneurysms producing chest pain. Journal of cardiothoracic surgery14 (1), 1-3.
  9. Smith, M. C., Schneller, A., Singh, A., & Rafeedheen, R. (2021). Giant Coronary Artery Aneurysms. Cureus13 (6).
  10. Gutierrez, N. G., Shirinsky, O., Gagarina, N., Lyskina, G., Fukazawa, R., Ogawa, S., … & Kahn, A. M. (2017). Assessment of coronary artery aneurysms caused by Kawasaki disease using transluminal attenuation gradient analysis of computerized tomography angiograms. The American journal of cardiology120 (4), 556-562.
  11. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association [published correction appears in Circulation. 2019 Jul 30;140(5):e181-e184].Circulation 2017;135(17):e927-e999.
  12. Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv 2018;11(13):1211-1223.
  13. Crawley PD, Mahlow WJ, Huntsinger DR, Afiniwala S, Wortham DC. Giant coronary artery aneurysms: review and update. Tex Heart Inst J2014;41(6):603-608.
  14. Szalat, A., Durst, R., Cohen, A., & Lotan, C. (2005). Use of polytetrafluoroethylene‐covered stent for treatment of coronary artery aneurysm. Catheterization and cardiovascular interventions66 (2), 203-208.
  15. Sheikh, A. S., Hailan, A., Kinnaird, T., Choudhury, A., & Smith, D. (2019). Coronary artery aneurysm: evaluation, prognosis, and proposed treatment strategies. Heart views: the official journal of the Gulf Heart Association20 (3), 101.